Compensation growth slowed slightly in the third quarter of the year, signaling that the white-hot labor market is cooling off.
The latest data from the Bureau of Labor Statistics‘ Employment Cost Index (ECI) shows that compensation costs, including wages and benefits, rose 0.8% from June to September. While still an increase, it marks a deceleration from the 0.9% growth in the second quarter. On an annual basis, compensation was up 3.6% in September—down from 3.9% in June and 4.3% a year ago.
Experts note that the tapering aligns with broader inflation trends, which have also been on a downward trajectory after hitting 40-year highs earlier in 2024. The data reinforces other indicators of a gradual cool-down, with moderating salary growth across all civilian workers and benefit cost increases slowing among private employers.
The Numbers Behind the Slowdown
Wages and salaries increased 0.8% quarter- over-quarter, while benefit costs were up 0.8% in Q3—both a notch below last quarter’s 0.9% rise. Over the last 12 months, wage growth for state and local government employees has fallen from 4.9% to 4.7%.
Meanwhile, benefits cost increases slowed dramatically, from 3.9% year-over-year in Q3 2023 to just 3.3% in Q3 2024. Experts say budgeted 2025 salary increases may follow suit, projecting minimal upticks from this year’s actual raises.
The Federal Reserve watches indicators like ECI closely when deciding interest rates. For employers planning 2025 compensation, the data signals that the rapid pace of pay hikes over the past few years may be ending. Moderation could allow benefits budgets some relief as well after sharp cost jumps.
For more Employee Benefits resouces, contact INSURICA today.
Copyright © 2025 Smarts Publishing. This is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel or an insurance professional for appropriate advice.
About the Author
Share This Story
Related Blogs
RxDC Reporting: What Employers Should Do Before the June 1 Deadline
Each year, group health plans must report detailed prescription drug and healthcare spending data to the Centers for Medicare & Medicaid Services (CMS). This reporting—commonly referred to as RxDC reporting—is due by June 1 and applies to most employer-sponsored group health plans that offer prescription drug coverage.
Chronic Condition Management 2.0: GLP-1 Alternatives and New Digital Therapeutics
Chronic conditions have long been the primary driver of employer healthcare spending, but 2026 marks a turning point in how organizations are approaching prevention, treatment, and long-term management. With GLP-1 medications dominating headlines — and budgets — employers are urgently exploring complementary or alternative strategies that can improve outcomes without unsustainable cost growth. The result is a new wave of digital therapeutics, metabolic health programs, and integrated care models that promise a more balanced approach to chronic disease management.
The Return-to-Office Reset: How Benefits Are Being Re-Engineered in 2026
After several years of experimentation, many employers are tightening hybrid schedules or requiring more in-office days. This “return-to-office reset” is reshaping benefits strategies as organizations look for ways to support commuting employees, improve onsite experience, and maintain flexibility. What began as a workplace policy shift is now driving a broader rethinking of how benefits can reinforce culture, productivity, and retention.